Mirum Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Foster City, CA
MIRM chart
What traders are saying about $MIRM
Latest postsMirum Pharmaceuticals, Inc. news
- Mirum Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 3, 2026
Business Wire ·
- Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo Finance ·
- Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans Progressiva
Yahoo Finance ·
- Form 8K Mirum Pharmaceuticals Inc For: 26 October By Investing.com
Investing.com Nigeria ·
- Mirum Pharmaceuticals, Inc. Announces Positive Results From Cohort 2 Of The Pivotal PROGRESS Study Of ATEBRIOZ In Pediatric Patients Aged 6 To
www.marketscreener.com ·
- Mirum Pharmaceuticals (MIRM) Edges Up 1.51% to $81.60, Holding the Middle of Its Range - Unusual Put Volume
https://www.dars.gov.et/ ·
- Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Positive Pediatric ATEBRIOZ Trial Results
Kalkine ·
- How Investors May Respond To Mirum Pharmaceuticals (MIRM) Phase 3 Trial Success
Simply Wall Street ·
- How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing
Stock Traders Daily ·
- Mirum Pharmaceuticals, Inc. Estimates – NASDAQ:MIRM
TradingView ·
- H.C. Wainwright Initiates Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Announces Target Price $195
Moomoo ·
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance ·
Mirum Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $521.3M | $336.9M | $186.4M | $77.1M |
| Net income | -$23.4M | -$87.9M | -$163.4M | -$135.7M |
| Diluted EPS | $-0.47 | $-1.85 | $-4.00 | $-4.02 |
| Total assets (year end) | $842.8M | $670.8M | $646.6M | $352.9M |
| Cash and equivalents (year end) | $296.7M | $222.5M | $286.3M | $28.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mirum Pharmaceuticals, Inc.
- Ticker
- MIRM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Foster City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1759425
Frequently asked questions
What exchange is Mirum Pharmaceuticals, Inc. listed on?
Mirum Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol MIRM.
What industry is Mirum Pharmaceuticals, Inc. in?
Mirum Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Mirum Pharmaceuticals, Inc. headquartered?
Mirum Pharmaceuticals, Inc.'s business address on file with the SEC is in Foster City, CA.
When does Mirum Pharmaceuticals, Inc.'s fiscal year end?
Mirum Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Mirum Pharmaceuticals, Inc. report?
Mirum Pharmaceuticals, Inc. reported $521.3M in revenue for calendar year 2025, according to its SEC filings.